TBP Antibody, Rabbit, Polyclonal

Artikelnummer: NSJ-F49784-0.08ML
Artikelname: TBP Antibody, Rabbit, Polyclonal
Artikelnummer: NSJ-F49784-0.08ML
Hersteller Artikelnummer: F49784-0.08ML
Alternativnummer: NSJ-F49784-0.08ML
Hersteller: NSJ Bioreagents
Wirt: Rabbit
Kategorie: Antikörper
Applikation: ELISA, FACS, IF, IHC, WB
Spezies Reaktivität: Human
Immunogen: A portion of amino acids 210-239 from the human protein was used as the immunogen for this TBP antibody.
Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. A distinctive feature of TBP is a long string of glutamines in the N-terminal. This region of the protein modulates the DNA binding activity of the C terminus, and modulation of DNA binding affects the rate of transcription complex formation and initiation of transcription. Mutations that expand the number of CAG repeats encoding this polyglutamine tract, and thus increase the length of the polyglutamine string, are associated with spinocerebellar ataxia 17, a neurodegenerative disorder classified as a polyglutamine disease.
Klonalität: Polyclonal
UniProt: P20226
Reinheit: Purified
Formulierung: In 1X PBS, pH 7.4, with 0.09% sodium azide
Antibody Type: Primary Antibody
Application Verdünnung: Western blot: 1:1000,Immunofluorescence: 1:10-1:50,IHC (Paraffin): 1:50-1:100,Flow Cytometry: 1:10-1:50
Anwendungsbeschreibung: Titration of the TBP antibody may be required due to differences in protocols and secondary/substrate sensitivity.